Astria Therapeutics, Inc. - Common Stock, par value $0.001 per share (ATXS)

CUSIP: 04635X102

Q4 2021 13F Holders as of 31 Dec 2021

Type / Class
Equity / Common Stock, par value $0.001 per share
Shares outstanding
57,127,897
Total 13F shares
6,093,269
Share change
-1,119,398
Total reported value
$32,840,000
Put/Call ratio
11%
Price per share
$5.39
Number of holders
29
Value change
-$7,416,469
Number of buys
12
Number of sells
13

Quarterly Holders Quick Answers

What is CUSIP 04635X102?
CUSIP 04635X102 identifies ATXS - Astria Therapeutics, Inc. - Common Stock, par value $0.001 per share in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Top shareholders of ATXS - Astria Therapeutics, Inc. - Common Stock, par value $0.001 per share (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.

Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
No top shareholder records were found across 13F, 13D/G, and Forms 3/4/5 for this issuer.

Institutional Holders of Astria Therapeutics, Inc. - Common Stock, par value $0.001 per share (ATXS) as of Q4 2021

As of 31 Dec 2021, Astria Therapeutics, Inc. - Common Stock, par value $0.001 per share (ATXS) was held by 29 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 6,093,269 shares. The largest 10 holders included PERCEPTIVE ADVISORS LLC, RA CAPITAL MANAGEMENT, L.P., Fairmount Funds Management LLC, Cormorant Asset Management, LP, VR Adviser, LLC, VANGUARD GROUP INC, Alyeska Investment Group, L.P., CITADEL ADVISORS LLC, Ikarian Capital, LLC, and GEODE CAPITAL MANAGEMENT, LLC. This page lists 29 institutional shareholders reporting positions in this security for the Q4 2021 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period

Compare Q4 2021 vs Q3 2021 Across Filers

Q3 2021 holders
32
Q4 2021 holders
29
Holder diff
-3
Investor Q3 2021 Shares Q4 2021 Shares Share Diff Share Chg % Q3 2021 Value $ Q4 2021 Value $ Value Diff $ Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Here you can make detailed settings or revoke your consent (in part if necessary) with effect for the future. For further information, please refer to our Privacy Policy .